Skip to main content

Table 1 Association of clinicopathological parameters and PROX1 expression

From: PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma

PROX1 expression

 

Low (0–1)

High (2–3)

 

n(%)

80 (51.9)

74 (48.1)

p-value

Age, years

   

  < 65

46 (57.5)

30 (40.5)

0.038

  ≥ 65

34 (42.5)

44 (59.5)

 

Gender

   

 Male

45 (56.3)

40 (54.1)

0.871

 Female

35 (43.7)

34 (45.9)

 

T

   

 1

5 (6.3)

7 (9.5)

0.274

 2

18 (22.5)

22 (29.7)

 

 3

56 (70.0)

43 (58.1)

 

 4

1 (1.3)

2 (2.7)

 

N

   

 0

23 (28.8)

25 (33.8)

0.602

 1

57 (71.2)

49 (66.2)

 

Stage (WHO)

   

 IA

4 (5.0)

5 (6.8)

0.550

 IB

8 (10.0)

10 (13.5)

 

 IIA

11 (13.8)

9 (12.2)

 

 IIB

56 (70.0)

48 (64.9)

 

 III

1 (1.3)

2 (2.7)

 

Lymph node ratio

   

  < 20 %

57 (71.3)

60 (83.3)

0.086

  ≥ 20 %

23 (28.7)

12 (16.7)

 

 Missing

 

2

 

Grade

   

 1

10 (14.7)

12 (19.0)

0.543

 2

47 (69.1)

42 (66.7)

 

 3

11 (16.2)

9 (14.3)

 

 Missing

12

11

 

Perineural invasion

   

 Yes

49 (73.1)

51 (82.3)

0.291

 No

18 (26.9)

11 (17.7)

 

 Missing

13

12

 

Perivascular invasion

 Yes

24 (36.9)

19 (32.2)

0.706

 No

41 (63.1)

40 (67.8)

 

 Missing

15

15

 
  1. Fischer exact-test was used for 2×2 tables and linear-by-linear association test for tables with more than two rows. Missing data excluded from the analyses